相关实验视频

Updated: Jun 8, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

分子预测/诊断研究的缺陷贫困人口中的研究

Arielle J Medford^1,2,3, Beverly Moy^1,2

¹Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.

JCO oncology practice

|November 12, 2024

概括

分子测试可以促进癌症治疗,但在不同的人群中,获取和有效性各不相同. 解决数据和试验的差异对于所有患者的公平癌症监测和治疗至关重要.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
健康公平卫生公平

背景情况:

分子分析提供个性化癌症监测,预后和治疗.
目前的分子工具有可能显著改善患者的治疗结果.
然而,这些先进检测的好处并非均等地分布在所有人群中.

研究的目的:

审查癌症临床分子试验的关键进展.
识别和分析这些工具的获取和应用方面的差异.
提出改善分子癌症护理公平性的干预措施.

主要方法:

关于分子测定进展的文献综述.
在基础基因组数据中对人口代表性的分析.
检查分子测定临床试验中的多样性.

主要成果:

缺乏服务的社区在获得新型分子分析方面存在显著差异.
基础数据和临床试验的有限多样性不成比例地影响某些祖先群体.
确定了导致这些差异的因素.

结论:

提高分子癌症护理的公平性需要解决进入障碍.
提高数据和临床试验的多样性对于公平的疗效至关重要.
需要全社区的干预措施,以确保所有患者从分子进步中受益.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...